DEA Meetings & Events
Upcoming Events:
Stimulant Safety in ADHD Virtual Seminar
The Diversion Control Division of the Drug Enforcement Administration is pleased to present a seminar about Stimulant Safety in ADHD.
Wednesday, September 3, 2025 | 1:00 p.m. to 3:00 p.m. EDT | ZOOM
There is no registration fee for this event. Capacity is limited to the first 3,000 attendees.
ADHD is the most common neurobehavioral disorder presenting for treatment. The stimulants including methylphenidate and amphetamine are among first line treatments, but the stimulants have abuse liability and the nonmedical use (NMU) including misuse and diversion has been of great interest to practitioners.
Data on the use of stimulants in ADHD, and the diversion and misuse of stimulants in those with and without a diagnosis of ADHD, will be examined during this seminar.
Speakers include:
- Timothy E. Wilens, MD, Chief of Child and Adolescent Psychiatry, Massachusetts General Hospital; Professor, Harvard Medical School
- Sean McCabe, PhD, Director of Center for the Study of Drugs, Alcohol, Smoking and Health (DASH Center); Professor, University of Michigan
- Matthew Strait, DEA Deputy Assistant Administrator
- Amy Yule, MD, Vice Chair, Addiction Psychiatry, Boston Medical Center; Associate Professor, Boston University
